The goal of hepatitis B antiviral treatment is to suppress liver inflammation, slow the progression of liver disease, and prevent hepatitis from progressing to liver fibrosis, cirrhosis, and liver cancer. Hepatitis B virus is a hepatophilic virus that replicates mainly in the human liver and can cause liver inflammation. Long-term liver inflammation can gradually lead to liver fibrosis, cirrhosis and even liver cancer. And antiviral treatment can inhibit the replication of hepatitis B virus, control liver inflammation and avoid progression to cirrhosis and liver cancer. For patients with liver fibrosis and some early cirrhosis, antiviral treatment can also achieve the reversal of liver fiber. This is due to the fact that antiviral treatment controls the replication of the virus, which is conducive to the repair and regeneration of liver cells, thus enabling the reversal of liver fibrosis. Hepatitis B patients should be standardized in liver disease clinics.